FDA Inspection 1146034 — North Texas Male Infertility Center, P.A.
The FDA completed an inspection of North Texas Male Infertility Center, P.A. on July 9, 2021 in Frisco, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 9, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Frisco, TX (United States)